Reversal of HIV drug resistance and novel strategies to curb HIV infection: The viral infectivity factor Vif as a target and tool of therapy

Current Drug Targets

Volumn 7, Issue 7, 2006, Pages 881-885

  Mezei, M ^a   Minarovits, J ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

Antiretroviral therapy; APOBEC3G; Defective HIV (dHIV); dNTP pool; Drug resistance; Human immunodeficiency virus (HIV); Mutation spectrum; Vif

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; CYTIDINE DEAMINASE; DEOXYNUCLEOTIDE TRIPHOSPHATE; DIDANOSINE; FLOXURIDINE; FLUOROURACIL; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYDROXYUREA; MUTANT PROTEIN; NUCLEOTIDE; PROTEIN ANTIBODY; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SINGLE STRANDED DNA; STAVUDINE; UNCLASSIFIED DRUG; VIF PROTEIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; CYTOPLASM; DISEASE COURSE; GENE CONSTRUCT; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN TARGETING; REVERSE TRANSCRIPTION; REVIEW; STOP CODON; TREATMENT FAILURE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; WILD TYPE;

AIDS VACCINES; ANTI-HIV AGENTS; DRUG RESISTANCE, MULTIPLE, VIRAL; GENE PRODUCTS, VIF; GENE THERAPY; HIV; HIV INFECTIONS; HUMANS; IMMUNOTHERAPY, ACTIVE;

EID: 33745757649     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006777709610     Document Type: Review

References (65)

1. Hahn B.H.; Shaw G.M.; De Cock K.M. and Sharp P. (2000) Science, 287, 607-614.
2. Simon V. And Ho D.D. (2003) Nat. Rev. Microbiol., 1, 181-190.
3. Roberts J.D.; Bebenek K. And Kunkel T.A. (1988) Science, 242, 1171-1173.
4. Burke D.S. (1997) Emerg. Infect. Dis., 3, 253-259.
5. Rhodes T.; Nikolaitchik O.; Chen J.; Powell D. and Hu W.S. (2005) J. Virol., 79, 1666-1677.
6. Sheehy A.M.; Gaddis N.C.; Choi J.D. and Malim M.H. (2002) Nature, 418, 646-650.
7. Chen L.; Perlina A. and Lee C.J. (2004) J. Virol., 78, 3722-3732.
8. Larder B.A. (1994) J. Gen. Virol., 75, 951-957.
9. Collins J.A.; Thompson M.G.; Paintsil E.; Ricketts M.; Gedzior J. and Alexander L. (2004) J. Virol., 78, 603-611.
10. Berkhout B. (1999) J. Biomed. Sci., 6, 298-305.
11. Miller V.; Sabin C.; Hertogs K.; Bloor S.; Martinez-Picado J.; D'Aquila R.; Larder B.; Lutz T.; Gute P.; Weidmann E.; Rabenau H.; Phillips A. and Staszewski S. (2000) AIDS, 14, 2857-2867.
12. Deeks S.G.; Wrin T.; Liegler T.; Hoh R.; Hayden M.; Barbour J.D.; Hellmn N.S.; Petropoulos C.J.; McCune J.M.; Hellerstein M.K. and Grant R.M. (2001) N. Engl. J. Med., 344, 472-480
13. Izopet J.; Souyris C.; Hance A.; Sandres-Saune K.; Alvarez M.; Pasquier C.; Clavel F.; Puel J. And Massip P. (2002) J. Infect. Dis., 185, 1506-0510.
14. Joly V.; Descamps D.; Peytavin G.; Touati, F.; Mentre, F.; Duval X.; Delarue S.; Yeni P. And Brun-Vezinet F. (2004) Antimicrobiol. Agents Chemother., 48, 172-175.
15. Pomerantz R.J. (2001) AIDS, 15, 1201-1211.
16. Gandhi R.T.; Wurcel A.; Rosenberg E.S.; Johnston M.N.; Hellmann N.; Bates M.; Hirsch M.S. and Walker B.D. (2003) Clin. Infect. Dis., 37, 1693-1698.
17. Kuritzkes D.R. (2001) PNAS, 98, 13485-13487.
18. Huang H.; Chopra R.; Verdine G.L. and Harrison S.C. (1998) Science, 282, 1669-1675.
19. Van Laethem K.; Witvrouw M.; Pannecouque C.; Van Remoortel B.; Schmit J.C.; Esnouf R.; Kleim J.P.; Balzarini J.; Desmyter J.; De Clercq E. and Vandamme A.M. (2001) AIDS, 15, 553-561.
20. Larder B.A.; Kellam P. and Kemp S.D. (1993) Nature, 365, 451-453.
21. Chen R.; Quinones-Mateu M.E. and Mansky L.M. (2004) Curr. Pharm. Res., 10, 4065-4070.
22. Menendez-Arias L.; Quinones-Mateu M.E. and Martinez-Picado J. (2003) Curr. Drug Targets Infect. Disord., 3, 355-371.
23. Nijhuis M.; Deeks S. and Boucher C. (2001) Curr. Opin. Infect. Dis., 14, 23-28.
24. Perno C.F.; Cenci A.; Piro C.; D'Arrigo R.; Marcon L.; Ceccherini-Silberstein F.; Ascoli Marchetti F.; Calio R. and Antinori A. (2003) Scand. J. Infect. Dis. Suppl., 106, 37-40.
25. Andreoni M. (2004) New Microbiol., 27(2 Suppl. 1) 71-76.
26. Gao W.Y.; Johns D.G.; Tanaka M. and Mitsuya H. (1999) Mol. Pharmacol., 55, 535-540.
27. Lori F.; Malykh A.G.; Foli A.; Maserati R.; De Antoni A.; Minoli L.; Padrini D.; Degli Antoni A.; Barchi E.; Jessen H.; Wainberg M.A.; Gallo R.C. and Lisziewicz J. (1997) AIDS Res. Hum. Retroviruses, 13, 1403-0409.
28. Fitzgerald D.J. Bronson E.C. and Anderson N.J. (1996) AIDS Res. Hum. Retroviruses, 12, 99-106.
29. Berkhout B. and van Hemert F.J. (1994) Nucleic Acids Res., 22, 1705-1711.
30. Gao F.; Chen Y.; Levy D.N; Conway J.A.; Kepler T.B. and Hui H. (2004) J. Virol., 78, 2426-2433.
31. Berkhout B.; Das A.T. and Beerens N. (2001) Science, 292, 7.
32. Martinez M. A;. Vartanian J.P. and Wain-Hobson S. (1994) PNAS, 91, 11787-11791.
33. Vartanian J.P.; Meyerhans A.; Asjö B. and Wain-Hobson S. (1991) J. Virol., 65, 1779-1788.
34. Vartanian J.P.; Meyerhans A.; Sala M. and Wain-Hobson S. (1994) PNAS, 91, 3090-3096.
35. van Hemert F.J. and Berkhout B. (1995) J. Mol. Evol., 41, 132-140.
36. Yusa K;. Oh-hara T.; Tsukahara S. and Tsuruo T. (1992) J. Biol. Chem., 267, 16848-16850.
37. Balzarini J.; Camarasa M.J.; Perez-Perez M.J.; San-Felix A.; Velazquey S.; Perno C.F.; De Clercq E.; Anderson J.N. and Karlsson A. (2001) J. Virol., 75, 5772-5777.
38. Suspene R.; Sommer P.; Henry M.; Ferris S.; Guetard D.; Pochet S.; Chester A.; Navaratnam N.; Wain-Hobson S. And Vartanian J.P. (2004) Nucleic Acids Res., 32, 2421-2429.
39. Yu Q.; Konig R.; Pillai S.; Chiles K.; Kearney M.; Palmer S.; Richman D.; Coffin J.M. and Landau N.R. (2004) Nat. Struct. Mol. Biol., 11, 435-442.
40. Bogerd H.P.; Doehle B.P.; Wiegand H.L. and Cullen B.R. (2004) PNAS, 101, 3770-3774.
41. Schrofelbauer B.; Chen D. and Landau N.R. (2004) PNAS, 101, 3927-3932.
42. Mangeat B.; Turelli P.; Liao S. And Trono D. (2004) J. Biol. Chem., 279, 14481-14483.
43. Jarmuz A.; Chester A.; Bayliss J.; Gisbourne J.; Dunhan I.; Scott J. and Navaratnam N. (2002) Genomics, 79, 285-296.
44. Zheng Y.H.; Irwin D.; Kurosu T.; Tokunaga K.; Sata T. and Peterlin B.M. (2004) J. Virol., 78, 6073-6076.
45. Wiegand H.L.; Doehle B.P.; Bogerd H.P. and Culler B.R. (2004) EMBO J., 23, 2451-2458.
46. Sawyer S.L.; Emerman M. and Malik H.S. (2004) PLOS Biology, 9, 1278-1285.
47. Harris R.S.; Bishop K.N.; Sheehy A.M.; Craig H.M.; Petersen-Mahrt S.K.; Watt I.N.; Neuberger M.S. and Malim M.H. (2003) Cell, 113, 803-809.
48. Lacossier D.; Bouchonnet F.; Clavel F. and Hance A.J. (2003) Science, 300, 1112.
49. Zhang H.; Yang B.; Pomerantz R.J.; Zhang C.; Arunachalam S.C. and Gao L. (2003) Nature, 424, 94-98.
50. Mangeat B.; Turelli P.; Caron G., Friedli M.; Perrin L. and Trono D. (2003) Nature, 424, 99-103.
51. Mehle A.; Strack B.; Ancuta P.; Zhang C.; McPike M. and Gabuzda D. (2004) J. Biol. Chem., 279, 7792-7798.
52. Yu X.; Yu Y.; Liu B.; Luo K.; Kong W.; Mao P. and Yu XF. (2003) Science, 302, 1056-1060.
53. Kao S.; Miyagi E.; Khan M.A.; Takeuchi H.; Opi S.; Goila-Gaur R. and Srebel K. (2004) Retrovirology, I:27.
54. Liu B.; Yu X.; Luo K.; Yu Y. and Yu X.F. (2004) J. Virol., 78, 2072-2081.
55. Simon J.H.; Miller D.L.; Fouchier R.A.; Soares M.A.; Peden K.W. and Malim M.H. (1998) EMBO J., 17, 1259-1267.
56. Kieffer T.A. Kwon P. Nettles R.E. Han Y. Ray S.C. and Siciliano R.F. (2005) J. Virol., 79, 1975-1980.
57. Janini M.; Rogers M.; Birx D.R. and McCutchan F.E. (2001) J. Virol., 75, 7939-7986.
58. Wei M. Xing H. Hong K. Huang H. Tang H. Qin G. and Shao Y. (2004) AIDS, 18, 1863-1865.
59. Berencsi G. Minarovits J. Nasz I. Foldes I. (1989) Med. Hypotheses, 30, 223-228.
60. Minarovits J. Berencsi G. Nasz I. Foldes I. (1988) Acta Microbiol. Hung., 35, 361-370.
61. Czub M. McAtee F.J. Czub S. Lynch W.P. and Portis J.L. (1995) Virology, 206, 372-380.
62. Rhodes D.I.; Ashrton L.; Solomon A.; Carr A.; Cooper D.; Caldor J. and Deacon N. (2000) J. Virol., 74, 10581-10588.
63. Brambilla A.; Turchetto L.; Gatti A.; Bovolenta C.; Veglia F.; Santagostino E.; Gingeri A.; Clementi M.; Poli G.; Bagnarelli P. and Vincenzi E. (1999) Virology, 259, 349-368.
64. Berkhout B. and de Ronde A. (2004) AIDS, 18, 1861-1863.
65. Jeffrey Fessel W. (2005) Med. Hypotheses, 64, 261-263.